Original InvestigationUtility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment
Under an Elsevier user license
open archive
Key Words
ankle–brachial index
coronary artery calcium
high-sensitivity C-reactive protein
pooled cohort equation
Abbreviations and Acronyms
ABI
ankle–brachial index
ACC
American College of Cardiology
AHA
American Heart Association
ASCVD
atherosclerotic cardiovascular disease
CAC
coronary artery calcium
CHD
coronary heart disease
CI
confidence interval
cPCE
calibrated pooled cohort equation
CT
computed tomography
DM
diabetes mellitus
FH
family history
hsCRP
high-sensitivity C-reactive protein
MI
myocardial infarction
NRI
net reclassification improvement
PCE
pooled cohort equation
Cited by (0)
This research was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040 and UL1-RR-025005 from the National Center for Research Resources. Dr. Psaty served on the Drug Safety Monitoring Board for a clinical trial funded by the device manufacturer (Zoll LifeCor) and served on the Drug Safety Monitoring Board of the Yale Open Data Access Project funded by Johnson & Johnson. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.